Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
Service des Urgences, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
Medicina (Kaunas). 2021 Jun 8;57(6):592. doi: 10.3390/medicina57060592.
An 83-year-old woman was admitted to the emergency department for a 7-day history of fatigue and progressive cyanosis in the feet and hands after cold exposure despite physical protective measures. Upon arrival, the patient presented with necrotic cutaneous lesions in both hands and distal lower extremities. Upon admission, hemoglobin was 7.6 g/dL and laboratory tests were consistent with cold agglutinin disease (CAD), the presence of monoclonal IgM, and flow cytometry consistent with lymphoplasmacytic lymphoma, but MYD88 L265P mutation was negative. The patient required blood transfusion, resulting in stabilized hemoglobin and a decrease in markers of hemolysis. Treatment with aspirin 250 mg daily and intravenous iloprost 0.5 mL/h was initiated with a poor clinical response at day 4. Amputation was required. Plasma exchange was performed and chemotherapy with rituximab and bendamustine was initiated. The clinical course was marked by further necrosis, prompting discussions regarding an additional amputation that was not performed considering the high surgical risk and refusal by the patient. Supportive treatment was initiated, and the patient expired one month after hospital admission.
一位 83 岁女性,因在寒冷暴露后出现 7 天疲劳和手足进行性发绀而入住急诊部,尽管采取了身体保护措施。入院时,患者双手和下肢远端均出现坏死性皮肤病变。入院时血红蛋白为 7.6g/dL,实验室检查符合冷凝集素病(CAD),存在单克隆 IgM,流式细胞术符合淋巴浆细胞淋巴瘤,但 MYD88 L265P 突变阴性。患者需要输血,血红蛋白稳定,溶血标志物下降。给予每日 250mg 阿司匹林和 0.5ml/h 静脉内伊洛前列素治疗,但第 4 天临床反应不佳。需要截肢。进行了血浆置换,并开始用利妥昔单抗和苯达莫司汀进行化疗。临床过程中出现进一步的坏死,促使讨论是否进行额外的截肢,但由于手术风险高和患者拒绝,未进行截肢。开始了支持性治疗,患者在入院后一个月死亡。